PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Despite the significant achievements in the diagnosis and treatment of metastatic breast cancer (MBC), this condition remains substantially an incurable disease. In recent years, several clinical studies have aimed to identify novel molecular targets, therapeutic strategies, and predictive biomarker...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Fusco, Nicola, Malapelle, Umberto, Fassan, Matteo, Marchiò, Caterina, Buglioni, Simonetta, Zupo, Simonetta, Criscitiello, Carmen, Vigneri, Paolo, Dei Tos, Angelo Paolo, Maiorano, Eugenio, Viale, Giuseppe
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8027489/
https://ncbi.nlm.nih.gov/pubmed/33842357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.644737
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados